ENTERAL NUTRITION MARKET ANALYSIS

The global enteral nutrition market is estimated to be valued at US$ 3.1 Billion in 2023 and is expected to exhibit a CAGR of 5.8% during the forecast period (2023-2030). The increasing incidence of cancer and the increasing number of preterm births are expected to drive market growth.

Analysts’ Views on Global Enteral Nutrition Market:

Enteral nutrition, also known as tube feeding, is a way of delivering nutrition directly to the stomach or small intestine. The increasing number of old age people who have difficulty in eating or swallowing is expected to drive market growth. Thus, rising number of elderly people is expected to show significant growth opportunities for the market over the forecast period

Figure 1. Global Enteral Nutrition Market Share (%), By Product Type, 2023

To learn more about this report, request sample copy

Global Enteral Nutrition Market – Drivers

• Increasing incidence of cancer: An increase in the prevalence of chronic diseases such as cancer is expected to increase the use of enteral nutrition in patient addimited to hospitals or long term care centers thus, this is expected to drive the market growth for the forecat period. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), on June 8, 2023, in the U.S. in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer.
• Increasing number of preterm births: A rise in the number of preterm births or premature birth is expected to increase the use of enteral nutrition and boost the demand for sip feeds to meet the nutritional requirements of newborns. For instance, according to an article published by the World Health Organization (WHO), on May 10, 2023, an estimated 13.4 million babies were born preterm in 2020 globally (before 37 weeks of gestation).

Figure 2. Global Enteral Nutrition Market Share (%), By Region, 2023

To learn more about this report, request sample copy

Global Enteral Nutrition Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global enteral nutrition market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023, and this is attributed to the presence of major players such as Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, and others, which contribute to the development of the enteral nutrition market in North America.

Global Enteral Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease had spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.

However, COVID-19 had a positive impact on the global enteral nutrition market as the use of enteral nutrition increased in patient suffering from COVID-19. COVID-19 is characterized by an inflammatory condition, which might decrease appetite and accelerate muscle degradation. Due to this significant risk of malnutrition in COVID-19 patients, nutritional management and malnutrition prevention are crucial parts of patient treatment. Therefore, the use of enteral nutrition during COVID-19 pandemic increased significantly. For instance, according to an article published in the National Library of Medicine, in March 2022, the effects of enteral nutrition in critically ill patients with COVID-19 suggest that overall, enteral nutrition was effective in significantly reducing the risk of mortality in these patients.

Global Enteral Nutrition Market Segmentation:

The global enteral nutrition market report is segmented into product type, nutrition type, formulation, patient type, application, distribution channel, end user, and region.

• By Product Type, the market is segmented into standard enteral nutrition and enteral nutrition for chronic illness. Out of which, the enteral nutrition for chronic illness segment is expected to hold a dominant position in the global enteral nutrition market during the forecast period, and this is attributed to an increase in the prevalence of chronic diseases.
• By Nutrition Type, the market is segmented into proteins, carbohydrates, multi-vitamins and antioxidants, amino acid, fibers, minerals, and others. Out of which, the proteins segment is expected to dominate the market over the forecast period, and this is attributed to increasing protein deficiency globally.
• By Formulation, the market is segmented into powder and liquid. Out of which, the liquid segment is expected to dominate the market over the forecast period, and this is attributed to increasing product launch by key market players.
• By Patient Type, the market is segmented into adult, pediatrics, and geriatrics. Out of which, the geriatrics segment is expected to dominate the market over the forecast period, and this is attributed to an increase in the number of old age people globally.
• By Application, the market is segmented into cancer, gastrointestinal diseases, diabetes, critical care, and others. Out of which, the cancer segment is expected to dominate the market over the forecast period, and this is attributed to an increase in the number of people suffering from cancer globally.
• By Distribution Channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Out of which, the hospital pharmacies segment is expected to dominate the market over the forecast period, and this is attributed to an increase in the number of hospitals and hospital pharmacies.
• By End User, the market is segmented into hospitals, home care settings, retirement homes, others. Out of which, the hospitals segment is expected to dominate the market over the forecast period, and this is attributed to an increase in the number of hospitals and hospital pharmacies.

Among all the segmentation, the application segment has the highest potential in the global enteral nutrition market and this is attributed to the increasing prevalence of chronic diseases such as cancer neurological disorders and others globally which requires the use of enteral nutrition

Global Enteral Nutrition Market- Cross Sectional Analysis:

By distribution channel, the hospital pharmacies segment held a dominant position in the Asia Pacific region in 2023, due to an increase in the number of hospitals and hospital pharmacies in this region. For instance, according to an article published by Asian Hospital & Healthcare Management in December 2022, there were more than 36,570 hospitals in China in 2021. Thus, the rising number of hospitals will eventually increase the number of hospital pharmacies.

Global Enteral Nutrition Market: Key Developments

• In May 2023, Otsuka Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, announced that it had launched ENORAS Liquid for enteral use, 200 kcal/125 mL, in two flavor coffee and tea flavor. The product is a concentrated (1.6 kcal/mL) polymeric enteric nutrition formula based on the latest nutritional information to efficiently provide nutrients and energy in a small amount.
• In May 2022, Abbott, a U.S.-based multinational healthcare company, announced the limited release of its EleCare branded specialty formulas, which have been developed for children and infants suffering from GI disorders or severe food allergies. The released products included EleCare Jr for ages one year and above; and EleCare for infants below 1 year of age.
• In April 2022, Meiji Co., Ltd., a Japan-based medical food manufacturing company, announced the launch of the baby formulas Meiji Hohoemi Infant Formula 800g, a powder milk product formula for infants to support the growth of the baby, in Japan

Global Enteral Nutrition Market: Key Trends

Inorganic strategies such as collaboration by key market players

Key market players are focused on inorganic growth strategies such as collaboration to develop technological advanced enteral nutrition solutions. For instance, in July 2020, Baxter, a global pharmaceutical cmpnay, and VIPUN Medical, a company developing technology solutions to help improve medical nutrition, collaborated to innovate and conduct research on a smart enteral feeding tube designed to measure stomach motility in order to help clinicians identify enteral feeding intolerance and make better informed nutrition therapy decisions in the intensive care unit (ICU) and other settings.

Global Enteral Nutrition Market: Restraint

• Increasing product recall: The factor that can act as an anchor to the growth of the global enteral nutrition market is the increasing number of product recall by key market players. For instance, in February 2022, Abbott announced a voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Mich., one of the company's manufacturing facilities, as the nutritional products were contaminated with bacteria and caused severe bacterial infection. As a result, the key market players should focus on adopting good manufacturing practices (GMP) and following striengent regulatory guidelines to limit such loss in the future.

Global Enteral Nutrition Market - Key Players

Major players operating in the global enteral nutrition market include Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.

Global Enteral Nutrition Market– Definition

Enteral nutrition is the use of feeding tubes to provide food to the gastrointestinal tract that contains carbs, proteins, water, fat, minerals, and vitamins. This type of nutrition is use in patient who have difficulty in swallowing food such as infants and geriatrics